These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29970686)

  • 1. Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer.
    Chen C; Zhu YH; Huang JA
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S336-S340. PubMed ID: 29970686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
    de Jong C; Deneer VHM; Kelder JC; Ruven H; Egberts TCG; Herder GJM
    Thorac Cancer; 2020 Jul; 11(7):1790-1800. PubMed ID: 32383328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
    He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
    Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
    Liu X; Zhang W; Yin W; Xiao Y; Zhou C; Hu Y; Geng S
    Medicine (Baltimore); 2017 Nov; 96(46):e8258. PubMed ID: 29145241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy.
    Wang C; Jin S; Xu S; Cao S
    Lung; 2020 Apr; 198(2):405-414. PubMed ID: 32016563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Utility of NSE, ProGRP and LDH in Diagnosis and Treatment
in Patients with Small Cell Lung Cancer].
    Peng Y; Wang Y; Li J; Hao X; Hu X
    Zhongguo Fei Ai Za Zhi; 2016 Sep; 19(9):590-4. PubMed ID: 27666548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
    Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
    Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum YKL-40 level is associated with the chemotherapy response and prognosis of patients with small cell lung cancer.
    Xu CH; Yu LK; Hao KK
    PLoS One; 2014; 9(5):e96384. PubMed ID: 24801872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients.
    Hong X; Xu Q; Yang Z; Wang M; Yang F; Gao Y; Zhou F; Wang L; Liu B; Chen G
    Clin Respir J; 2018 Feb; 12(2):433-447. PubMed ID: 27460525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
    Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
    Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
    Zhang C; Jia Y; Jia Y; Zhang X; Li K
    Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
    Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
    Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
    Shirasawa M; Fukui T; Kusuhara S; Hiyoshi Y; Nakahara Y; Nishinarita N; Igawa S; Naoki K
    BMC Cancer; 2019 Feb; 19(1):163. PubMed ID: 30808322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L.
    Liu R; Cao J; Gao X; Zhang J; Wang L; Wang B; Guo L; Hu X; Wang Z
    Tumour Biol; 2016 Oct; 37(10):14083-14088. PubMed ID: 27511116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum biomarkers of non-neuron-endocrine origin in small-cell lung cancer: a 16-year study on carcinoembryonic antigen, tissue polypeptide antigen and lactate dehydrogenase.
    Buccheri G; Ferrigno D;
    Lung Cancer; 2000 Oct; 30(1):37-49. PubMed ID: 11008008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Survivin Protein Levels in Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
    Puskas R; Bikov A; Horvath P; Lazar Z; Kunos L; Nagy R; Pinter G; Galffy G
    Pathol Oncol Res; 2021; 27():631969. PubMed ID: 34257598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer.
    Li J; Wu MF; Lu HW; Chen Q; Lin ZQ; Wang LJ
    Cancer Med; 2016 Aug; 5(8):1863-72. PubMed ID: 27350066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J
    Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.
    Tas F; Aydiner A; Demir C; Topuz E
    Am J Clin Oncol; 2001 Aug; 24(4):376-8. PubMed ID: 11474266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.